News Platform features

SeqOne unlocks the power of Illumina’s TruSightTM Oncology 500

27 September 2021

With the addition of the TSO500 pan-cancer NGS assay for genomic profiling of tumour samples, SeqOne now provides oncologists with the most comprehensive genomic data analytics solution for fast, actionable results. 
SeqOne offers a powerful genomic analysis platform capable of detecting the complex variants that are critical to cancer diagnosis and treatment.  

Get in touch and find out how SeqOne can provide more actionable insights from your genomics data  contact@seqone.com.

Need help improving your genomic analysis process ?
We'd love to help !